Account Bag 0

PRODUCT PROFILE

SS-31 (Elamipretide)

£29.99

SS-31 (Elamipretide) is mitochondria-targeting aromatic-cationic tetrapeptide; generic name elamipretide. Researchers examine it in relation to cardiolipin, oxidative phosphorylation and mitochondrial-disease outcomes.

Why it is distinct

Directly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.

  • Evidence stageClinical research
  • AvailabilityUnavailable
  • Batch recordOpen COA
  • DispatchConfirmed at checkout

Out of stock

Ask about availability
SKU: ADINA-AGE-SS-31-10MG Category: Tags: , ,

SUGGESTED ADD-ONS

Useful additions, clearly shown.

Suggestions are organised by vial format and catalogue context. They are not combined-use guidance or personal-use advice.

PRODUCT INFORMATION

Clear first. Detailed when needed.

What this material is+

SS-31 (Elamipretide) is mitochondria-targeting aromatic-cationic tetrapeptide; generic name elamipretide. Researchers examine it in relation to cardiolipin, oxidative phosphorylation and mitochondrial-disease outcomes.

Research focus+

Researchers study whether it can protect mitochondrial membranes and improve how cells make energy. Human trials exist, but benefits vary by condition and it remains investigational in many settings.

How the mechanism differs+

Concentrates at the inner mitochondrial membrane and interacts with cardiolipin to influence electron transport and membrane stability.

Evidence and limitations+

Multiple human trials exist, including mixed or unmet primary endpoints; development remains condition-specific.

Testing and batch documentation+

Verified batch documents are available for review.

RESEARCH PROFILE

Understand the distinction.

Molecular role

Mitochondria-targeting aromatic-cationic tetrapeptide; generic name elamipretide

Research focus

Researchers study whether it can protect mitochondrial membranes and improve how cells make energy. Human trials exist, but benefits vary by condition and it remains investigational in many settings.

How it works

Concentrates at the inner mitochondrial membrane and interacts with cardiolipin to influence electron transport and membrane stability.

Key differentiator

Directly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.

Evidence context

Multiple human trials exist, including mixed or unmet primary endpoints; development remains condition-specific.

Educational research context only. This information is not dosage, administration or personal-use guidance.

WhatsApp